Abstract
Overview
Introduction
High profile drug withdrawals and negative public attention has placed drug
safety at the top of the pharmaceutical industry' s agenda. This report will
examine pharmacovigilance technology solutions designed to alleviate the
challenges in drug safety management faced by the pharmaceutical industry and
the regulatory agencies.
Scope
- Identifies the key forces driving the adoption of pharmacovigilance
technology solutions
- Analyzes the crucial issues that will impede the uptake of drug safety
monitoring tools
- Discusses the key functionalities needed for a complete pharmacovigilance
solution
- Offers insight into how IT vendors can improve their products
Report Highlights
Pharma companies must adapt to constantly changing government regulations to
ensure compliance and eventual approval of their drug products, and response
to these new rules is driving the adoption of pharmacovigilance solutions.
It is essential for pharma companies to implement proactive pharmacovigilance
strategies which encompass strong data management systems, signal detection
technologies, and adverse event reporting systems to ensure production of a
safe and effective drug that will be approved and will maintain a favorable
risk-benefit ratio post-approval.
The industry is still skeptical of the benefits provided by signal detection
technologies. IT vendors must take an active role in educating companies about
these technologies, and position signal detection as an essential tool for
developing comprehensive risk management strategies which will not only
benefit the company, but ultimately the public.
Reasons to Purchase
- Validate your market messaging and positioning in the pharmaceutical
industry
- Identify strategies that will increase adoption of pharmacovigilance
technologies
- Understand the technology trends that are shaping the future of drug safety
View Cart
